Novo Nordisk's pricing strategies within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of selling price gouging, pointing out the stark distinction in between U.S. costs and people in Europe and copyright.Allergic response: You should not choose Rybelsus or copyright When you are allergic